ArticleSultan Qaboos University medical journal2024

Managing the Adverse Events Associated with Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer.

Aref Zribi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.